CADTH joint final guidance on reporting real-world evidence studies in Canada

CADTH, in association with Health Canada and INESSS, has produced the final guidance for regulatory and health technology assessment agencies in Canada to advance the integration of real-world evidence in healthcare decision making. Here we provide a background on the development of the final guidance and summarize the key recommendations made. Growing need for RWE guidance CADTH (Canadian Agency for Drugs and Technologies in Health), along with Health Canada and the Institut national d’excellence en santé et en services sociaux (INESSS), has announced the publication of a new guidance document, called ‘Guidance for Reporting Real-World Evidence.’ The final guidance, published...